| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amino Acid Transport System y+ | 14 | 2024 | 32 | 4.740 |
Why?
|
| Lipid Peroxidation | 15 | 2024 | 161 | 4.720 |
Why?
|
| Cystine | 7 | 2023 | 33 | 4.150 |
Why?
|
| Iron | 11 | 2024 | 379 | 3.110 |
Why?
|
| Neoplasms | 33 | 2024 | 15849 | 3.060 |
Why?
|
| Cell Death | 15 | 2024 | 689 | 2.850 |
Why?
|
| AMP-Activated Protein Kinases | 8 | 2024 | 405 | 2.720 |
Why?
|
| Mitochondria | 7 | 2024 | 1318 | 2.240 |
Why?
|
| Disulfides | 4 | 2023 | 111 | 2.110 |
Why?
|
| Energy Metabolism | 9 | 2020 | 1005 | 2.080 |
Why?
|
| Tumor Suppressor Proteins | 10 | 2019 | 1885 | 1.950 |
Why?
|
| RNA, Long Noncoding | 6 | 2018 | 618 | 1.940 |
Why?
|
| Ubiquitin Thiolesterase | 4 | 2022 | 224 | 1.870 |
Why?
|
| Mitochondrial Proteins | 3 | 2022 | 386 | 1.740 |
Why?
|
| Kidney Neoplasms | 8 | 2024 | 3142 | 1.640 |
Why?
|
| Glucose | 13 | 2023 | 1249 | 1.610 |
Why?
|
| Forkhead Transcription Factors | 7 | 2018 | 774 | 1.570 |
Why?
|
| Cell Line, Tumor | 32 | 2024 | 14864 | 1.550 |
Why?
|
| Carcinoma, Renal Cell | 7 | 2024 | 2412 | 1.520 |
Why?
|
| HEK293 Cells | 15 | 2024 | 1473 | 1.410 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 7 | 2021 | 275 | 1.330 |
Why?
|
| Stress, Physiological | 6 | 2020 | 493 | 1.290 |
Why?
|
| Homeostasis | 6 | 2018 | 960 | 1.190 |
Why?
|
| Coenzyme A Ligases | 3 | 2022 | 15 | 1.150 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2020 | 195 | 1.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2021 | 9078 | 1.100 |
Why?
|
| Ubiquinone | 2 | 2022 | 33 | 1.010 |
Why?
|
| Histones | 4 | 2020 | 1510 | 1.010 |
Why?
|
| Lipid Peroxides | 2 | 2024 | 23 | 1.000 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2020 | 1372 | 0.990 |
Why?
|
| 1-Acylglycerophosphocholine O-Acyltransferase | 1 | 2024 | 2 | 0.980 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2024 | 10 | 0.980 |
Why?
|
| Signal Transduction | 24 | 2024 | 12206 | 0.970 |
Why?
|
| Animals | 55 | 2024 | 62771 | 0.960 |
Why?
|
| Glutathione | 6 | 2024 | 377 | 0.920 |
Why?
|
| Electron Transport Complex I | 1 | 2024 | 67 | 0.920 |
Why?
|
| Glucose Transporter Type 1 | 3 | 2020 | 62 | 0.910 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2024 | 78 | 0.880 |
Why?
|
| Humans | 79 | 2024 | 270947 | 0.860 |
Why?
|
| Ubiquitination | 4 | 2022 | 577 | 0.860 |
Why?
|
| Protein Kinases | 4 | 2020 | 917 | 0.850 |
Why?
|
| Apoptosis | 16 | 2024 | 7847 | 0.850 |
Why?
|
| Mice | 42 | 2024 | 35992 | 0.850 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2022 | 7 | 0.840 |
Why?
|
| Neoplasm Proteins | 3 | 2020 | 3349 | 0.800 |
Why?
|
| Sulfhydryl Compounds | 1 | 2021 | 70 | 0.790 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 2 | 2020 | 60 | 0.790 |
Why?
|
| GTP Cyclohydrolase | 1 | 2021 | 7 | 0.790 |
Why?
|
| Multiprotein Complexes | 6 | 2016 | 388 | 0.780 |
Why?
|
| Sarcoma, Synovial | 1 | 2022 | 130 | 0.760 |
Why?
|
| TOR Serine-Threonine Kinases | 9 | 2016 | 1571 | 0.760 |
Why?
|
| BRCA1 Protein | 1 | 2024 | 516 | 0.750 |
Why?
|
| Cysteine | 2 | 2023 | 215 | 0.750 |
Why?
|
| Metabolomics | 2 | 2021 | 507 | 0.750 |
Why?
|
| Adenine | 1 | 2024 | 667 | 0.740 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 2 | 2024 | 513 | 0.720 |
Why?
|
| Genes, myc | 2 | 2022 | 373 | 0.710 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2021 | 593 | 0.700 |
Why?
|
| Immunotherapy | 3 | 2024 | 3532 | 0.700 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2020 | 72 | 0.700 |
Why?
|
| Cell Survival | 7 | 2024 | 3081 | 0.700 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2020 | 54 | 0.700 |
Why?
|
| Reperfusion Injury | 2 | 2024 | 155 | 0.700 |
Why?
|
| Transcription Factors | 12 | 2016 | 5494 | 0.700 |
Why?
|
| Organelles | 1 | 2020 | 46 | 0.690 |
Why?
|
| Proteomics | 2 | 2024 | 1435 | 0.690 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2021 | 210 | 0.680 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 188 | 0.680 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2022 | 623 | 0.660 |
Why?
|
| Radiation, Ionizing | 1 | 2020 | 191 | 0.660 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 4182 | 0.660 |
Why?
|
| Stromal Interaction Molecule 2 | 1 | 2018 | 1 | 0.650 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 390 | 0.650 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2024 | 3920 | 0.640 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2011 | 1293 | 0.640 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2023 | 489 | 0.620 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 274 | 0.580 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2024 | 94 | 0.580 |
Why?
|
| Reactive Oxygen Species | 6 | 2024 | 1011 | 0.570 |
Why?
|
| Phenformin | 1 | 2016 | 5 | 0.570 |
Why?
|
| Glycolysis | 2 | 2019 | 533 | 0.570 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2022 | 1409 | 0.550 |
Why?
|
| Neuroblastoma | 1 | 2022 | 701 | 0.550 |
Why?
|
| HMGB Proteins | 1 | 2016 | 13 | 0.540 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2024 | 879 | 0.540 |
Why?
|
| Tuberculosis | 1 | 2023 | 617 | 0.530 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 337 | 0.520 |
Why?
|
| Cell Cycle Proteins | 7 | 2020 | 2125 | 0.510 |
Why?
|
| Glutamic Acid | 1 | 2017 | 336 | 0.500 |
Why?
|
| Embryo, Mammalian | 5 | 2020 | 757 | 0.500 |
Why?
|
| Lung Neoplasms | 4 | 2022 | 11761 | 0.490 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 540 | 0.490 |
Why?
|
| Phosphorylation | 11 | 2020 | 4985 | 0.490 |
Why?
|
| Cells, Cultured | 9 | 2021 | 5782 | 0.480 |
Why?
|
| Mice, Nude | 6 | 2021 | 4360 | 0.480 |
Why?
|
| Mice, Knockout | 16 | 2024 | 5837 | 0.480 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 2016 | 1836 | 0.460 |
Why?
|
| Cellular Senescence | 1 | 2016 | 390 | 0.450 |
Why?
|
| Radiotherapy | 1 | 2021 | 1858 | 0.450 |
Why?
|
| Kidney | 2 | 2020 | 2261 | 0.450 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2023 | 3657 | 0.430 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 671 | 0.420 |
Why?
|
| Autophagy | 5 | 2022 | 920 | 0.420 |
Why?
|
| Piperazines | 5 | 2023 | 2153 | 0.420 |
Why?
|
| Calcium | 1 | 2018 | 1598 | 0.410 |
Why?
|
| Ribosomal Protein S6 Kinases | 3 | 2006 | 123 | 0.410 |
Why?
|
| Glutamine | 3 | 2020 | 329 | 0.410 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 4 | 2007 | 163 | 0.400 |
Why?
|
| Antiviral Agents | 1 | 2019 | 1255 | 0.400 |
Why?
|
| Cyclohexylamines | 2 | 2022 | 17 | 0.390 |
Why?
|
| Cell Cycle | 5 | 2011 | 2151 | 0.390 |
Why?
|
| Phospholipids | 2 | 2022 | 171 | 0.380 |
Why?
|
| Gene Deletion | 6 | 2021 | 1482 | 0.380 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 2 | 2022 | 106 | 0.370 |
Why?
|
| Sulfasalazine | 2 | 2020 | 12 | 0.370 |
Why?
|
| Autophagy-Related Proteins | 9 | 2021 | 54 | 0.360 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2014 | 815 | 0.350 |
Why?
|
| Carcinogenesis | 4 | 2022 | 1030 | 0.350 |
Why?
|
| HeLa Cells | 5 | 2018 | 1719 | 0.340 |
Why?
|
| Mice, Inbred NOD | 3 | 2021 | 911 | 0.330 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2024 | 272 | 0.320 |
Why?
|
| Up-Regulation | 5 | 2021 | 2465 | 0.320 |
Why?
|
| Cell Size | 2 | 2006 | 145 | 0.320 |
Why?
|
| F-Box Proteins | 1 | 2009 | 99 | 0.320 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2022 | 257 | 0.310 |
Why?
|
| Glucose Transporter Type 3 | 2 | 2020 | 11 | 0.310 |
Why?
|
| Cell Membrane | 2 | 2022 | 907 | 0.300 |
Why?
|
| Proteins | 3 | 2010 | 2047 | 0.300 |
Why?
|
| Membrane Proteins | 2 | 2021 | 2953 | 0.300 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2018 | 557 | 0.290 |
Why?
|
| Forkhead Box Protein O1 | 5 | 2014 | 167 | 0.290 |
Why?
|
| Mice, SCID | 3 | 2021 | 1855 | 0.290 |
Why?
|
| Enzyme Activation | 4 | 2016 | 1834 | 0.290 |
Why?
|
| Radiation Tolerance | 2 | 2021 | 635 | 0.280 |
Why?
|
| Oxidative Stress | 2 | 2023 | 1158 | 0.280 |
Why?
|
| Lactic Acid | 2 | 2019 | 312 | 0.280 |
Why?
|
| Fibroblasts | 4 | 2020 | 1669 | 0.280 |
Why?
|
| Cell Differentiation | 6 | 2023 | 4191 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2093 | 0.270 |
Why?
|
| Cell Movement | 4 | 2018 | 2500 | 0.260 |
Why?
|
| Hydrogen Peroxide | 2 | 2024 | 225 | 0.260 |
Why?
|
| NADP | 2 | 2023 | 91 | 0.260 |
Why?
|
| Blotting, Western | 4 | 2016 | 3648 | 0.260 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2016 | 3655 | 0.250 |
Why?
|
| Antineoplastic Agents | 4 | 2024 | 14679 | 0.250 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2016 | 1014 | 0.250 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2024 | 9 | 0.240 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2024 | 9 | 0.230 |
Why?
|
| Iron Overload | 1 | 2024 | 34 | 0.230 |
Why?
|
| Vitamin K Epoxide Reductases | 1 | 2023 | 7 | 0.230 |
Why?
|
| Quinolines | 2 | 2020 | 402 | 0.230 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2024 | 87 | 0.230 |
Why?
|
| Endoribonucleases | 1 | 2024 | 110 | 0.220 |
Why?
|
| Lipid Droplets | 1 | 2024 | 56 | 0.220 |
Why?
|
| Copper | 1 | 2024 | 166 | 0.220 |
Why?
|
| RNA, Small Nucleolar | 1 | 2023 | 25 | 0.220 |
Why?
|
| RNA Stability | 1 | 2024 | 133 | 0.220 |
Why?
|
| Vitamin K | 1 | 2023 | 55 | 0.220 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2024 | 1725 | 0.220 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2023 | 7240 | 0.220 |
Why?
|
| Lipolysis | 1 | 2023 | 108 | 0.210 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 2984 | 0.210 |
Why?
|
| Actin Cytoskeleton | 1 | 2023 | 79 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 10 | 2024 | 7216 | 0.210 |
Why?
|
| Malate Dehydrogenase | 1 | 2022 | 20 | 0.210 |
Why?
|
| Protein Kinase C beta | 1 | 2022 | 35 | 0.210 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2022 | 85 | 0.200 |
Why?
|
| Endopeptidases | 1 | 2023 | 233 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 5 | 2019 | 3245 | 0.200 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2021 | 21 | 0.200 |
Why?
|
| Warfarin | 1 | 2023 | 152 | 0.200 |
Why?
|
| Phospholipases | 1 | 2021 | 12 | 0.200 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 4371 | 0.200 |
Why?
|
| Lipocalin-2 | 1 | 2021 | 70 | 0.200 |
Why?
|
| Plasmalogens | 1 | 2021 | 7 | 0.200 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2021 | 53 | 0.190 |
Why?
|
| Oxidants | 1 | 2021 | 51 | 0.190 |
Why?
|
| Unfolded Protein Response | 2 | 2024 | 114 | 0.190 |
Why?
|
| Tumor Escape | 1 | 2023 | 248 | 0.190 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2021 | 6 | 0.190 |
Why?
|
| Pyrazoles | 2 | 2020 | 1542 | 0.190 |
Why?
|
| Triglycerides | 1 | 2024 | 618 | 0.190 |
Why?
|
| Eukaryotic Cells | 1 | 2021 | 51 | 0.190 |
Why?
|
| Gossypol | 1 | 2021 | 28 | 0.190 |
Why?
|
| Liver | 2 | 2011 | 3126 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 1617 | 0.190 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 1467 | 0.180 |
Why?
|
| Female | 18 | 2024 | 148509 | 0.180 |
Why?
|
| Phosphogluconate Dehydrogenase | 1 | 2020 | 9 | 0.180 |
Why?
|
| Lipids | 1 | 2024 | 659 | 0.180 |
Why?
|
| Formaldehyde | 1 | 2020 | 116 | 0.180 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2020 | 26 | 0.180 |
Why?
|
| Fanconi Anemia | 1 | 2020 | 90 | 0.180 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 272 | 0.180 |
Why?
|
| Heart | 1 | 2006 | 1211 | 0.180 |
Why?
|
| Phenylenediamines | 1 | 2020 | 23 | 0.180 |
Why?
|
| Glutathione Peroxidase | 1 | 2020 | 64 | 0.170 |
Why?
|
| Cell Proliferation | 7 | 2014 | 7294 | 0.170 |
Why?
|
| Biphenyl Compounds | 1 | 2021 | 192 | 0.170 |
Why?
|
| A549 Cells | 1 | 2020 | 127 | 0.170 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2020 | 86 | 0.170 |
Why?
|
| Transfection | 3 | 2019 | 3172 | 0.170 |
Why?
|
| Carrier Proteins | 3 | 2014 | 2123 | 0.170 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 203 | 0.170 |
Why?
|
| Gastrointestinal Agents | 1 | 2020 | 118 | 0.170 |
Why?
|
| Fluorouracil | 1 | 2024 | 1985 | 0.170 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 335 | 0.170 |
Why?
|
| Pyrimidines | 2 | 2023 | 3667 | 0.160 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 580 | 0.160 |
Why?
|
| Forkhead Box Protein O3 | 3 | 2014 | 109 | 0.160 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 80 | 0.160 |
Why?
|
| Telomerase | 2 | 2012 | 533 | 0.160 |
Why?
|
| Biological Transport | 1 | 2020 | 647 | 0.160 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 202 | 0.160 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 553 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1084 | 0.150 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein D | 1 | 2017 | 11 | 0.150 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2023 | 841 | 0.150 |
Why?
|
| Absorption, Physiological | 1 | 2017 | 6 | 0.150 |
Why?
|
| Heterografts | 1 | 2020 | 745 | 0.150 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 3459 | 0.150 |
Why?
|
| Ketoglutaric Acids | 1 | 2017 | 44 | 0.150 |
Why?
|
| Tunicamycin | 1 | 2017 | 19 | 0.150 |
Why?
|
| Repressor Proteins | 1 | 2005 | 1726 | 0.150 |
Why?
|
| Transcription Factor CHOP | 1 | 2017 | 24 | 0.140 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 2 | 2014 | 31 | 0.140 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2017 | 31 | 0.140 |
Why?
|
| Recombinant Proteins | 2 | 2017 | 3075 | 0.140 |
Why?
|
| Protein Binding | 4 | 2014 | 3536 | 0.140 |
Why?
|
| Transcription, Genetic | 5 | 2020 | 3416 | 0.140 |
Why?
|
| Subcellular Fractions | 1 | 2016 | 213 | 0.140 |
Why?
|
| Macrophages | 1 | 2023 | 1368 | 0.140 |
Why?
|
| Transplantation, Heterologous | 2 | 2016 | 1089 | 0.140 |
Why?
|
| Oxygen | 1 | 2021 | 799 | 0.140 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 718 | 0.140 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2021 | 896 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2021 | 2109 | 0.130 |
Why?
|
| NF-kappa B | 2 | 2021 | 1583 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2022 | 2471 | 0.130 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 154 | 0.130 |
Why?
|
| Medical Oncology | 1 | 2024 | 1462 | 0.130 |
Why?
|
| DNA Repair | 2 | 2020 | 1886 | 0.120 |
Why?
|
| DNA Damage | 2 | 2020 | 1980 | 0.120 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 315 | 0.120 |
Why?
|
| Antioxidants | 1 | 2018 | 521 | 0.120 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 594 | 0.120 |
Why?
|
| Embryonic Development | 2 | 2007 | 315 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 2 | 2021 | 1469 | 0.120 |
Why?
|
| Survival Analysis | 2 | 2020 | 9307 | 0.120 |
Why?
|
| Everolimus | 1 | 2017 | 438 | 0.120 |
Why?
|
| Precision Medicine | 1 | 2022 | 1201 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 1547 | 0.120 |
Why?
|
| RNA Interference | 2 | 2016 | 1398 | 0.120 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 5161 | 0.120 |
Why?
|
| Gene Expression | 2 | 2016 | 3681 | 0.120 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 352 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 672 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 2 | 2013 | 1215 | 0.110 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 7461 | 0.110 |
Why?
|
| Breast Neoplasms | 6 | 2024 | 16186 | 0.110 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2013 | 63 | 0.110 |
Why?
|
| Oncogenes | 1 | 2016 | 700 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2013 | 423 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 1432 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 512 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 594 | 0.100 |
Why?
|
| Telomere Homeostasis | 1 | 2012 | 70 | 0.100 |
Why?
|
| DNA-Binding Proteins | 3 | 2016 | 5042 | 0.100 |
Why?
|
| Glioblastoma | 2 | 2013 | 1777 | 0.090 |
Why?
|
| MicroRNAs | 2 | 2016 | 2906 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 2490 | 0.090 |
Why?
|
| Pancytopenia | 1 | 2010 | 119 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2013 | 481 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2020 | 2736 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2399 | 0.090 |
Why?
|
| Hypoglycemia | 1 | 2011 | 221 | 0.090 |
Why?
|
| Hyperlipidemias | 1 | 2011 | 236 | 0.090 |
Why?
|
| NIH 3T3 Cells | 2 | 2006 | 260 | 0.080 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2009 | 56 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 1212 | 0.080 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2009 | 81 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2015 | 1229 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 6248 | 0.080 |
Why?
|
| Telomere | 1 | 2012 | 534 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 715 | 0.080 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 2317 | 0.080 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2008 | 23 | 0.080 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 1019 | 0.080 |
Why?
|
| Phenotype | 2 | 2010 | 6465 | 0.080 |
Why?
|
| Focal Adhesion Kinase 1 | 2 | 2005 | 116 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2010 | 391 | 0.080 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 1733 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2014 | 2034 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 6789 | 0.070 |
Why?
|
| Imidazoles | 1 | 2014 | 1059 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 4956 | 0.070 |
Why?
|
| Integrases | 1 | 2008 | 266 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2010 | 606 | 0.070 |
Why?
|
| Esophageal Neoplasms | 1 | 2021 | 3236 | 0.070 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2006 | 19 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 631 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2006 | 38 | 0.070 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 4788 | 0.070 |
Why?
|
| Base Sequence | 1 | 2013 | 5496 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2013 | 1108 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 1147 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2011 | 5834 | 0.070 |
Why?
|
| Vasodilation | 1 | 1987 | 218 | 0.070 |
Why?
|
| Axons | 1 | 2009 | 443 | 0.070 |
Why?
|
| Fetal Death | 1 | 2006 | 135 | 0.070 |
Why?
|
| B7-H1 Antigen | 1 | 2013 | 1057 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 496 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 843 | 0.060 |
Why?
|
| Genes, src | 1 | 2005 | 28 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2013 | 6483 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 1987 | 445 | 0.060 |
Why?
|
| Skin Diseases | 1 | 2008 | 368 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2006 | 308 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 181 | 0.060 |
Why?
|
| Enzyme Induction | 1 | 2005 | 262 | 0.060 |
Why?
|
| Mutation | 3 | 2023 | 15854 | 0.060 |
Why?
|
| Lipid Metabolism | 2 | 2023 | 499 | 0.060 |
Why?
|
| Rabbits | 1 | 2006 | 1089 | 0.060 |
Why?
|
| Metalloendopeptidases | 1 | 2005 | 176 | 0.060 |
Why?
|
| Endocytosis | 1 | 2005 | 239 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 2214 | 0.060 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2024 | 29 | 0.060 |
Why?
|
| Cell Division | 1 | 2008 | 2716 | 0.060 |
Why?
|
| Polyamines | 1 | 2024 | 80 | 0.060 |
Why?
|
| Genomic Instability | 2 | 2020 | 522 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2006 | 1046 | 0.060 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2023 | 35 | 0.060 |
Why?
|
| Rejuvenation | 1 | 2023 | 23 | 0.060 |
Why?
|
| Mammary Glands, Animal | 1 | 2007 | 635 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2007 | 1037 | 0.060 |
Why?
|
| S Phase | 1 | 2024 | 290 | 0.050 |
Why?
|
| Stem Cells | 1 | 2010 | 1230 | 0.050 |
Why?
|
| Vitamin A | 1 | 2023 | 91 | 0.050 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2016 | 148 | 0.050 |
Why?
|
| Models, Biological | 2 | 2011 | 3226 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2022 | 40 | 0.050 |
Why?
|
| Retinoids | 1 | 2023 | 154 | 0.050 |
Why?
|
| Gestational Age | 1 | 2006 | 1143 | 0.050 |
Why?
|
| Time Factors | 1 | 2016 | 13112 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2023 | 189 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2021 | 58 | 0.050 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2018 | 1004 | 0.050 |
Why?
|
| Cell Line | 2 | 2006 | 5437 | 0.050 |
Why?
|
| Adipocytes | 1 | 2023 | 308 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2018 | 2474 | 0.050 |
Why?
|
| Neoplasm Metastasis | 3 | 2018 | 5324 | 0.050 |
Why?
|
| Autophagosomes | 1 | 2021 | 40 | 0.050 |
Why?
|
| Myocardium | 1 | 2006 | 1249 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2008 | 2434 | 0.050 |
Why?
|
| Tretinoin | 1 | 2023 | 621 | 0.050 |
Why?
|
| Arginine | 1 | 2024 | 509 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2022 | 337 | 0.050 |
Why?
|
| K562 Cells | 1 | 2020 | 345 | 0.040 |
Why?
|
| Male | 8 | 2024 | 128454 | 0.040 |
Why?
|
| Biological Assay | 1 | 2021 | 182 | 0.040 |
Why?
|
| Survival Rate | 1 | 2013 | 12516 | 0.040 |
Why?
|
| Chemokines | 2 | 2011 | 293 | 0.040 |
Why?
|
| Inflammation | 1 | 2008 | 2527 | 0.040 |
Why?
|
| Proteome | 1 | 2022 | 572 | 0.040 |
Why?
|
| Neurons | 1 | 2009 | 2465 | 0.040 |
Why?
|
| Lysosomes | 1 | 2021 | 347 | 0.040 |
Why?
|
| Prognosis | 2 | 2013 | 22458 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 514 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 958 | 0.040 |
Why?
|
| Pregnancy | 2 | 2007 | 8043 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 4983 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2016 | 154 | 0.030 |
Why?
|
| Starvation | 1 | 2015 | 26 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 5990 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 1119 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 5233 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 1526 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2021 | 2851 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 10698 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2015 | 179 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 7936 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2013 | 174 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2013 | 153 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 214 | 0.030 |
Why?
|
| Epithelial Cells | 2 | 2011 | 1887 | 0.030 |
Why?
|
| Genes, cdc | 1 | 2012 | 84 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 254 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2013 | 184 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 163 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 2011 | 130 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 1135 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2012 | 270 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 366 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 4067 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2940 | 0.020 |
Why?
|
| Phagosomes | 1 | 2009 | 72 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 435 | 0.020 |
Why?
|
| Neurites | 1 | 2009 | 70 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 5106 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 2159 | 0.020 |
Why?
|
| Lymphoma, T-Cell | 1 | 2012 | 369 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 2307 | 0.020 |
Why?
|
| Sirolimus | 1 | 2013 | 831 | 0.020 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2008 | 50 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2008 | 247 | 0.020 |
Why?
|
| Cyclin D | 1 | 2007 | 40 | 0.020 |
Why?
|
| Tachyphylaxis | 1 | 1987 | 2 | 0.020 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2008 | 118 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2008 | 135 | 0.020 |
Why?
|
| Chromatin | 1 | 2013 | 1050 | 0.020 |
Why?
|
| Celiac Artery | 1 | 1987 | 43 | 0.020 |
Why?
|
| Renal Artery | 1 | 1987 | 88 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 1987 | 66 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2008 | 577 | 0.020 |
Why?
|
| Milk Proteins | 1 | 2007 | 134 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2011 | 1287 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 1437 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2009 | 279 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1987 | 284 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2007 | 227 | 0.020 |
Why?
|
| Femoral Artery | 1 | 1987 | 203 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 1153 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 1987 | 248 | 0.020 |
Why?
|
| Lactation | 1 | 2007 | 244 | 0.020 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 2005 | 8 | 0.020 |
Why?
|
| Cerebellum | 1 | 2009 | 476 | 0.020 |
Why?
|
| Cyclins | 1 | 2007 | 470 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1574 | 0.020 |
Why?
|
| Arteries | 1 | 1987 | 294 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 738 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2006 | 97 | 0.020 |
Why?
|
| Dogs | 1 | 1987 | 1168 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 556 | 0.020 |
Why?
|
| Dynamins | 1 | 2005 | 78 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1543 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 10250 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 686 | 0.010 |
Why?
|
| G1 Phase | 1 | 2005 | 306 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2006 | 280 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 2264 | 0.010 |
Why?
|
| Tyrosine | 1 | 2005 | 510 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2005 | 589 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1987 | 643 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2005 | 533 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2005 | 603 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 6982 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 7813 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 1502 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 90021 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 6893 | 0.010 |
Why?
|
| Cytokines | 1 | 2008 | 2836 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 4644 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 2669 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 5411 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 30941 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 33827 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 73161 | 0.010 |
Why?
|